Health & Bio

FDA clears Lecanemab home injection; BeiGene sofocrelax MCL approval

Alzheimer's home access expands. BCL-2 market competition intensifies.

Primary sources · 2
BrightFocusTargeted Oncology
← View the full 2026-05-21 (Thu) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →